Cover image
市場調查報告書 - 225456

學名藥:全球市場的聯盟的機會

Generic Drugs: Global collaboration opportunities

出版商 Espicom Business Intelligence
出版日期 2014年01月20日 內容資訊 英文 438 Pages
價格
學名藥:全球市場的聯盟的機會 Generic Drugs: Global collaboration opportunities
出版日期: 2014年01月20日 內容資訊: 英文 438 Pages
簡介

學名藥市場,是有助於對更多人提供有效產品的方法。這有關於新的先進品牌產品的成本上升,促成學名藥市場的迅速擴大。傳統提供品牌醫藥品為主的市場,也越來越多轉移至非專利處方。可是,醫療費的壓力也對非專利價格打壓。低利益對學名藥企業來說成為煩惱的原因。

本報告提供全球42個國家的160家中堅學名藥製造企業調查分析,為您概述為以下內容。

主要的調查內容

  • 企業概要
  • 企業背景
  • 產品範圍
  • 財務資訊
  • 主要的開發趨勢
  • 聯絡處資訊

調查對象企業

  • 阿根廷
    • Laboratorios Phoenix
  • 澳洲
    • Alchemia
  • 孟加拉國
    • Beximco Pharmaceuticals
  • 巴西
    • Hypermarcas
    • LAFEPE
    • moksha8
  • 保加利亞
    • Sopharma
  • 加拿大
    • AA Pharma
    • BioVectra
    • Intellipharmaceutics International
  • 智利
    • CFR Pharmaceuticals
  • 中國
    • Aoxing Pharmaceutical
    • China Pharma Holdings
    • Rxmidas/GRMIDAS
    • Zhejiang Huahai Pharmaceuticals
  • 賽普勒斯
    • Medochemie
  • 埃及
    • EIPICo
  • 法國
    • BioAlliance Pharma
  • 德國
    • Alfred E Tiefenbacher (AET)
  • 希臘
    • Genepharm
    • Pharmathen
  • 印度
    • Alembic
    • Alkem
    • Bafna Pharmaceuticals
    • Bharat Serums and Vaccines
    • Biocon
    • Claris Lifesciences
    • Emcure
    • Gland Pharma
    • Glenmark Pharmaceuticals
    • Granules India
    • Hetero Drugs
    • Indoco Remedies
    • Intas Pharmaceuticals
    • Ipca Laboratories
    • JB Chemicals & Pharmaceuticals
    • Jubilant Life Sciences
    • Macleods Pharmaceuticals
    • Marksans Pharma
    • Micro Labs
    • Natco Pharma
    • Orchid Chemicals & Pharmaceuticals
    • RPG Life Sciences
    • Shasun Pharmaceuticals
    • Strides Arcolab
    • Torrent Pharmaceuticals
    • Unichem Laboratories
    • Venus Remedies
  • 愛爾蘭
    • Consilient Health
    • Reliance GeneMedix
  • 義大利
    • ACS Dobfar
  • 日本
    • Nichi-Iko Pharmaceutical
    • Nippon Chemipher
    • 東和藥品
  • 約旦
    • Hikma Pharmaceuticals
  • 肯亞
    • Regal Pharmaceuticals
  • 拉脫維亞
    • Grindeks
  • 立陶宛
    • Sanitas
  • 馬來西亞
    • Inno Biologics
    • Pharmaniaga Berhad
  • 墨西哥
    • Genomma Lab
  • 荷蘭
    • Genmed Holding
    • Synthon
  • 紐西蘭
    • Douglas Pharmaceuticals
  • 挪威
    • Navamedic
  • 阿曼
    • Oman Pharmaceutical Products
  • 波蘭
    • Polpharm
  • 葡萄牙
    • Hovione
  • 羅馬尼亞
    • Antibiotice
  • 俄羅斯
    • R-Pharm
  • 南非
    • Adcock Ingram
    • Cipla Medpro
    • Litha Healthcare
    • Pharma Dynamics
    • Sonke Pharmaceuticals
  • 韓國
    • Hanmi Pharmaceutical
  • 西班牙
    • Laboratorios Cinfa
  • 瑞典
    • Bluefish Pharmaceuticals
  • 瑞士
    • Acino
    • Legacy Pharmaceuticals International
  • 台灣
    • ScinoPharm Taiwan
  • 泰國
    • Government Pharmaceutical Organisation
  • 土耳其
    • Abdi Ibrahim
    • EastPharma
    • Mustafa Nevzat Pharmaceuticals
  • 英國
    • Amdipharm Mercury (AMCo)
    • Kent Pharmaceuticals
    • Syntropharma
  • 美國
    • Acella Pharmaceuticals
    • Aceto
    • Akorn
    • Alvogen
    • Amerigen Pharmaceuticals
    • Amneal Pharmaceuticals
    • Amphastar Pharmaceuticals
    • Antares Pharma
    • Apicore
    • AustarPharma
    • Avanthi
    • Bedford Laboratories
    • Belcher Pharmaceuticals
    • Biokey
    • Boca Pharmacal
    • Breckenridge Pharmaceutical
    • Cambrex
    • Carlsbad Technology
    • Cephazone Pharma
    • CorePharma
    • Cypress Pharmaceutical
    • Elite Pharmaceuticals
    • Epic Pharma
    • EPIRUS Biopharmaceuticals
    • Exela
    • Ferndale Pharma Group
    • Fougera
    • G&W Laboratories
    • GeneraMedix Pharmaceuticals
    • Greenstone
    • Handa Pharmaceuticals
    • Hanford Pharmaceuticals
    • Harris Pharmaceutical
    • Hi-Tech Pharmacal
    • IGI Laboratories
    • Indicus Pharma
    • InvaGen Pharmaceuticals
    • Kadmon Pharmaceuticals
    • Kremers Urban Pharmaceuticals
    • KVK-Tech
    • Lehigh Valley Technologies
    • Luitpold Pharmaceuticals
    • Lyne Laboratories
    • Mallinckrodt
    • Mikart
    • Nexgen Pharma
    • Nexus Pharmaceuticals
    • Nostrum Pharmaceuticals
    • Novel Laboratories
    • Orit Laboratories
    • Osmotica Pharmaceutical
    • Patheon
    • Pharmaceutical Associates
    • Prasco Laboratories
    • Precision Dose
    • Qualitest Pharmaceuticals
    • Roxane Laboratories
    • Sigmapharm Laboratories
    • Silarx Pharmaceuticals
    • SOHM
    • Spear Pharmaceuticals
    • Stason Pharmaceuticals 4
    • Tolmar
    • Tris Pharma
    • Upsher-Smith Laboratories
    • VersaPharm
    • VistaPharm
    • X-GEN Pharmaceutical
  • 越南
    • Nanogen Biopharmaceutical

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Key facts, statistics and insights on 160 medium-sized generic manufacturers based in 42 countries!

Collaboration is the key to growth

With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.

At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of branded medicines have made moves to increase generic prescribing.

But pressure on health spending is seeing downward pressure on generic prices. With lower margins this is creating pain for generics companies.

SME Generic companies offer focused opportunities

With established markets compromised, where can the industry go? Expansion in the sector has been seen through more partnering, either through outright acquisition to increase market share or through product and marketing licensing. Being bigger and having improved market access is seen as a way of distributing cost and strengthening revenues. While major players such as Teva and Sandoz play an international role, there are a number of established and progressive generic manufacturers worthy of consideration.

Use this report to...

  • Identify commercial partners to secure new markets, technologies and revenues
  • Assess merger and acquisition targets
  • Understand the developing generic industry in key markets worldwide
  • Profile the competitive environment in the increasingly important medium-sized company sector
  • Seek out companies manufacturing/marketing similar product lines
  • Assess the investment potential of these key companies

Find and assess potential partners and acquisition targets with this report

This new report from Espicom is a key resource for the wide assessment of 160 medium-sized generic companies operating in 42 markets worldwide. The report provides an essential and comprehensive evaluation of each company:

  • Location, establishment and full contact details
  • Financial information, where available
  • Products and/or therapy areas
  • Recent strategic alliances

Delivering the key content you need...

  • Background
    A summary of the company's foundation and main business interests
  • Product range
    Details of ANDAs approved or products/therapy areas represented
  • Financial
    Financial performance or funding data
  • Strategic alliances
    Details of significant marketing and supply agreements
  • Contact information
    Postal, telephone, fax and website details

About the Author: Generic Drugs: Global Collaboration Opportunities has been researched and written by Espicom editors: Alex Gates and Ian Platts. In addition to this report, Ian edits the leading newsletter World Generic Markets and has monitored the generics market for over 10 years.

Table of Contents

  • Companies In This Report 1
    • Company Details In Focus 8

Argentina 17

  • Laboratorios Phoenix 17
    • Snapshot 17
    • Background 17
    • Products 17
    • Major Developments 17
    • Contact Details 18

Australia 19

  • Alchemia 19
    • Snapshot 19
    • Background 19
    • Products 19
    • Financials 20
    • Major Developments 20
    • Contact Details 21

Bangladesh 22

  • Beximco Pharmaceuticals 22
    • Snapshot 22
    • Background 22
    • Products 22
    • Financials 23
    • Major Developments 23
    • Contact Details 24

Brazil 25

  • Hypermarcas 25
    • Snapshot 25
    • Background 25
    • Products 25
    • Financials 25
    • Major Developments 26
    • Contact Details 27
  • LAFEPE 28
    • Snapshot 28
    • Background 28
    • Products 28
    • Major Developments 29
    • Contact Details 29
  • moksha8 30
    • Snapshot 30
    • Background 30
    • Products 30
    • Major Developments 30
    • Contact Details 31

Bulgaria 32

  • Sopharma 32
    • Snapshot 32
    • Background 32
    • Products 32
    • Financials 32
    • Contact Details 33

Canada 34

  • AA Pharma 34
    • Snapshot 34
    • Background 34
    • Products 34
    • Contact Details 35
  • BioVectra 36
    • Snapshot 36
    • Background 36
    • Products 36
    • Major Developments 36
    • Contact Details 37
  • Intellipharmaceutics International 38
    • Snapshot 38
    • Background 38
    • Products 38
    • Financials 38
    • Major Developments 39
    • Contact Details 40

Chile 41

  • CFR Pharmaceuticals 41
    • Snapshot 41
    • Background 41
    • Products 42
    • Financials 42
    • Major Developments 42
    • Contact Details 43

China 44

  • Aoxing Pharmaceutical 44
    • Snapshot 44
    • Background 44
    • Products 44
    • Financials 44
    • Major Developments 45
    • Contact Details 46
  • China Pharma Holdings 47
    • Snapshot 47
    • Background 47
    • Products 47
    • Financials 47
    • Contact Details 48
  • Rxmidas/GRMIDAS 49
    • Snapshot 49
    • Background 49
    • Products 49
    • Financials 49
    • Major Developments 49
    • Contact Details 50
  • Zhejiang Huahai Pharmaceuticals 51
    • Snapshot 51
    • Background 51
    • Products 51
    • Contact Details 51

Cyprus 52

  • Medochemie 52
    • Snapshot 52
    • Background 52
    • Products 52
    • Contact Details 52

Egypt 53

  • EIPICo 53
    • Snapshot 53
    • Background 53
    • Products 53
    • Contact Details 53

France 54

  • BioAlliance Pharma 54
    • Snapshot 54
    • Background 54
    • Financials 55
    • Major Developments 55
    • Contact Details 57

Germany 58

  • Alfred E Tiefenbacher (AET) 58
    • Snapshot 58
    • Background 58
    • Products 58
    • Major developments 58
    • Contact Details 59
  • Fresenius Kabi 60
    • Snapshot 60
    • Background 60
    • Products 60
    • Financials 62
    • Major Developments 62
    • Contact Details 64

Greece 65

  • Genepharm 65
    • Snapshot 65
    • Background 65
    • Products 65
    • Contact Details 66
  • Pharmathen 67
    • Snapshot 67
    • Background 67
    • Products 67
    • Financials 67
    • Contact Details 67

India 68

  • Alembic 68
    • Snapshot 68
    • Background 68
    • Products 68
    • Financials 69
    • Major Developments 70
    • Contact Details 71
  • Alkem 72
    • Snapshot 72
    • Background 72
    • Products 72
    • Major Developments 73
    • Contact Details 73
  • Bafna Pharmaceuticals 74
    • Snapshot 74
    • Background 74
    • Products 74
    • Financials 75
    • Major Developments 75
    • Contact Details 76
  • Bharat Serums and Vaccines 77
    • Snapshot 77
    • Background 77
    • Products 77
    • Contact Details 78
  • Biocon 79
    • Snapshot 79
    • Background 79
    • Products 79
    • Financials 80
    • Major Developments 81
    • Contact Details 83
  • Claris Lifesciences 84
    • Snapshot 84
    • Background 84
    • Products 84
    • Financials 85
    • Major Developments 86
    • Contact Details 87
  • Emcure 88
    • Snapshot 88
    • Background 88
    • Products 88
    • Major Developments 89
    • Contact Details 89
  • Gland Pharma 90
    • Snapshot 90
    • Background 90
    • Products 90
    • Major Developments 90
    • Contact Details 91
  • Glenmark Pharmaceuticals 92
    • Snapshot 92
    • Background 92
    • Products 92
    • Financials 94
    • Major Developments 96
    • Contact Details 97
  • Granules India 98
    • Snapshot 98
    • Background 98
    • Products 98
    • Financials 99
    • Major Developments 99
    • Contact Details 99
  • Hetero Drugs 100
    • Snapshot 100
    • Background 100
    • Products 100
    • Major Developments 101
    • Contact Details 103
  • Indoco Remedies 104
    • Snapshot 104
    • Background 104
    • Products 104
    • Financials 105
    • Major Developments 105
    • Contact Details 106
  • Intas Pharmaceuticals 107
    • Snapshot 107
    • Background 107
    • Products 107
    • Financials 108
    • Major Developments 108
    • Contact Details 109
  • Ipca Laboratories 110
    • Snapshot 110
    • Background 110
    • Products 110
    • Financials 110
    • Contact Details 112
  • JB Chemicals & Pharmaceuticals 113
    • Snapshot 113
    • Background 113
    • Products 113
    • Financials 113
    • Major Developments 114
    • Contact Details 115
  • Jubilant Life Sciences 116
    • Snapshot 116
    • Background 116
    • Products 116
    • Financials 117
    • Major Developments 118
    • Contact Details 119
  • Macleods Pharmaceuticals 120
    • Snapshot 120
    • Background 120
    • Products 120
    • Contact Details 121
  • Marksans Pharma 122
    • Snapshot 122
    • Background 122
    • Products 122
    • Financials 122
    • Contact Details 123
  • Micro Labs 124
    • Snapshot 124
    • Background 124
    • Products 124
    • Major Developments 124
    • Contact Details 125
  • Natco Pharma 126
    • Snapshot 126
    • Background 126
    • Products 126
    • Financials 127
    • Major Developments 128
    • Contact Details 130
  • Orchid Chemicals & Pharmaceuticals 131
    • Snapshot 131
    • Background 131
    • Products 131
    • Financials 133
    • Major Developments 133
    • Contact Details 134
  • RPG Life Sciences 135
    • Snapshot 135
    • Background 135
    • Products 135
    • Financials 135
    • Major Developments 136
    • Contact Details 136
  • Shasun Pharmaceuticals 137
    • Snapshot 137
    • Background 137
    • Products 137
    • Financials 137
    • Major Developments 138
    • Contact Details 139
  • Strides Arcolab 140
    • Snapshot 140
    • Background 140
    • Products 140
    • Financials 142
    • Major Developments 143
    • Contact Details 145
  • Torrent Pharmaceuticals 146
    • Snapshot 146
    • Background 146
    • Products 146
    • Financials 147
    • Major Developments 148
    • Contact Details 149
  • Unichem Laboratories 150
    • Snapshot 150
    • Background 150
    • Products 150
    • Financials 151
    • Major Developments 152
    • Contact Details 152
  • Venus Remedies 153
    • Snapshot 153
    • Background 153
    • Products 153
    • Financials 153
    • Major Developments 154
    • Contact Details 154

Ireland 155

  • Consilient Health 155
    • Snapshot 155
    • Background 155
    • Products 155
    • Contact Details 156
  • Reliance GeneMedix 157
    • Snapshot 157
    • Background 157
    • Products 157
    • Financials 157
    • Major Developments 158
    • Contact Details 159

Italy 160

  • ACS Dobfar 160
    • Snapshot 160
    • Background 160
    • Products 160
    • Contact Details 161

Japa n 162

  • Nichi-Iko Pharmaceutical 162
    • Snapshot 162
    • Background 162
    • Products 162
    • Financials 162
    • Major Developments 163
    • Contact Details 163
  • Nippon Chemiphar 164
    • Snapshot 164
    • Background 164
    • Products 164
    • Financials 164
    • Contact Details 165
  • Towa Pharmaceutical 166
    • Snapshot 166
    • Background 166
    • Products 166
    • Financials 166
    • Contact Details 167

Jorda n 168

  • Hikma Pharmaceuticals 168
    • Snapshot 168
    • Background 168
    • Products 168
    • Financials 171
    • Major Developments 171
    • Contact Details 175

Kenya 176

  • Regal Pharmaceuticals 176
    • Snapshot 176
    • Background 176
    • Products 176
    • Contact Details 176

La tvia 177

  • Grindeks 177
    • Snapshot 177
    • Background 177
    • Products 177
    • Financials 177
    • Major Developments 178
    • Contact Details 179

Lithuania 180

  • Sanitas 180
    • Snapshot 180
    • Background 180
    • Products 180
    • Financials 181
    • Major Developments 182
    • Contact Details 182

Malaysia 183

  • CCM Pharmaceuticals 183
    • Snapshot 183
    • Background 183
    • Products 183
    • Financials 184
    • Major Developments 184
    • Contact Details 185

Malaysia 186

  • Inno Biologics 186
    • Snapshot 186
    • Background 186
    • Products 186
    • Contact Details 187
  • Pharmaniaga Berhad 188
    • Snapshot 188
    • Background 188
    • Products 188
    • Financials 188
    • Major Developments 189
    • Contact Details 189

Mexic o 190

  • Genomma Lab 190
    • Snapshot 190
    • Background 190
    • Products 190
    • Financials 190
    • Contact Details 191

Netherlands 192

  • Genmed Holding 192
    • Snapshot 192
    • Background 192
    • Products 192
    • Financials 192
    • Major Developments 193
    • Contact Details 193
  • Synthon 194
    • Snapshot 194
    • Background 194
    • Products 194
    • Major Developments 195
    • Contact Details 196

New Zealand 197

  • Douglas Pharmaceuticals 197
    • Snapshot 197
    • Background 197
    • Products 197
    • Financials 197
    • Contact Details 198

Norway 199

  • Navamedic 199
    • Snapshot 199
    • Background 199
    • Products 199
    • Financials 200
    • Major Developments 200
    • Contact Details 201

Oman 202

  • Oman Pharmaceutical Products 202
    • Snapshot 202
    • Background 202
    • Products 202
    • Major Developments 202
    • Contact Details 203

Poland 204

  • Polpharma 204
    • Snapshot 204
    • Background 204
    • Products 204
    • Major Developments 204
    • Contact Details 206

Portugal 207

  • Hovione 207
    • Snapshot 207
    • Background 207
    • Products 207
    • Financials 208
    • Major Developments 208
    • Litigation 208
    • Contact Details 208

Roma nia 209

  • Antibiotice 209
    • Snapshot 209
    • Background 209
    • Products 209
    • Financials 209
    • Major Developments 210
    • Contact Details 210

Russia 211

  • R-Pharm 211
    • Snapshot 211
    • Background 211
    • Products 211
    • Financials 211
    • Major Developments 212
    • Contact Details 212

South Africa 213

  • Adcock Ingram 213
    • Snapshot 213
    • Background 213
    • Products 214
    • Financials 216
    • Major Developments 218
    • Contact Details 221
  • Cipla Medpro 222
    • Snapshot 222
    • Background 222
    • Products 222
    • Financials 223
    • Major Developments 224
    • Contact Details 225
  • Litha Healthcare 226
    • Snapshot 226
    • Background 226
    • Products 226
    • Financials 226
    • Major Developments 227
    • Contact Details 228
  • Pharma Dynamics 229
    • Snapshot 229
    • Background 229
    • Products 229
    • Contact Details 229
  • Sonke Pharmaceuticals 230
    • Snapshot 230
    • Background 230
    • Products 230
    • Major Developments 230
    • Contact Details 231

South Korea 232

  • Hanmi Pharmaceutical 232
    • Snapshot 232
    • Background 232
    • Products 232
    • Financials 233
    • Major Developments 234
    • Contact Details 236

Spain 237

  • Laboratorios Cinfa 237
    • Snapshot 237
    • Background 237
    • Products 237
    • Financials 237
    • Major Developments 238
    • Contact Details 238

Sweden 239

  • Bluefish Pharmaceuticals 239
    • Snapshot 239
    • Background 239
    • Products 239
    • Financials 239
    • Major Developments 240
    • Contact Details 241

Switzerland 242

  • Acino 242
    • Snapshot 242
    • Background 242
    • Products 242
    • Financials 243
    • Major Developments 243
    • Contact Details 245
  • Legacy Pharmaceuticals International 246
    • Snapshot 246
    • Background 246
    • Products 246
    • Contact Details 246

Taiwan 247

  • ScinoPharm Taiwan 247
    • Snapshot 247
    • Background 247
    • Products 248
    • Financials 248
    • Major Developments 249
    • Contact Details 250

Thailand 251

  • Government Pharmaceutical Organisation 251
    • Snapshot 251
    • Background 251
    • Products 251
    • Contact Details 252

Turkey 253

  • Abdi Ibrahim 253
    • Snapshot 253
    • Background 253
    • Products 253
    • Major Developments 254
    • Contact Details 254
  • EastPharma 255
    • Snapshot 255
    • Background 255
    • Products 255
    • Financials 255
    • Contact Details 256
  • Mustafa Nevzat Pharmaceuticals 257
    • Snapshot 257
    • Background 257
    • Products 257
    • Major Developments 258
    • Contact Details 258

UK 259

  • Amdipharm Mercury (AMCo) 259
    • Snapshot 259
    • Background 259
    • Products 260
    • Financials 260
    • Major Developments 261
    • Contact Details 261
  • Kent Pharmaceuticals 262
    • Snapshot 262
    • Background 262
    • Products 262
    • Major Developments 262
    • Contact Details 263
  • Syntropharma 264
    • Snapshot 264
    • Background 264
    • Products 264
    • Major Developments 264
    • Contact Details 265

USA 266

  • Acella Pharmaceuticals 266
    • Snapshot 266
    • Background 266
    • Products 266
    • Contact Details 266
  • Aceto 267
    • Snapshot 267
    • Background 267
    • Products 267
    • Financials 267
    • Contact Details 268
  • Akorn 269
    • Snapshot 269
    • Background 269
    • Products 270
    • Financials 271
    • Major Developments 272
    • Contact Details 273
  • Alvogen 274
    • Snapshot 274
    • Background 274
    • Products 274
    • Major Developments 275
    • Contact Details 277
  • Amerigen Pharmaceuticals 278
    • Snapshot 278
    • Background 278
    • Products 278
    • Major Developments 278
    • Contact Details 280
  • Amneal Pharmaceuticals 281
    • Snapshot 281
    • Background 281
    • Products 281
    • Major Developments 283
    • Contact Details 284
  • Amphastar Pharmaceuticals 285
    • Snapshot 285
    • Background 285
    • Products 285
    • Major Developments 286
    • Contact Details 287
  • Antares Pharma 288
    • Snapshot 288
    • Background 288
    • Products 288
    • Financials 289
    • Major Developments 289
    • Contact Details 290
  • Apicore 291
    • Snapshot 291
    • Background 291
    • Products 291
    • Contact Details 292
  • AustarPharma 293
    • Snapshot 293
    • Background 293
    • Products 293
    • Major Developments 293
    • Contact Details 294
  • Avanthi 295
    • Snapshot 295
    • Background 295
    • Products 295
    • Contact Details 295
  • Bedford Laboratories 296
    • Snapshot 296
    • Background 296
    • Products 296
    • Major Developments 298
    • Contact Details 299
  • Belcher Pharmaceuticals 300
    • Snapshot 300
    • Background 300
    • Products 300
    • Contact Details 300
  • Biokey 301
    • Snapshot 301
    • Background 301
    • Products 301
    • Contact Details 301
  • Boca Pharmacal 302
    • Snapshot 302
    • Background 302
    • Products 302
    • Major Developments 302
    • Contact Details 303
  • Breckenridge Pharmaceutical 304
    • Snapshot 304
    • Background 304
    • Products 304
    • Major Developments 304
    • Contact Details 306
  • Cambrex 307
    • Snapshot 307
    • Background 307
    • Products 307
    • Financials 307
    • Major Developments 308
    • Contact Details 309
  • Carlsbad Technology 310
    • Snapshot 310
    • Background 310
    • Products 310
    • Contact Details 310
  • Cephazone Pharma 311
    • Snapshot 311
    • Background 311
    • Products 311
    • Contact Details 311
  • CorePharma 312
    • Snapshot 312
    • Background 312
    • Products 312
    • Major Developments 313
    • Contact Details 313
  • Cypress Pharmaceutical 314
    • Snapshot 314
    • Background 314
    • Products 314
    • Major Developments 314
    • Contact Details 315
  • Elite Pharmaceuticals 316
    • Snapshot 316
    • Background 316
    • Products 316
    • Financials 316
    • Major Developments 317
    • Contact Details 318
  • Epic Pharma 319
    • Snapshot 319
    • Background 319
    • Products 319
    • Major Developments 319
    • Contact Details 320
  • EPIRUS Biopharmaceuticals 321
    • Snapshot 321
    • Background 321
    • Products 321
    • Major Developments 321
    • Contact Details 322
  • Exela 323
    • Snapshot 323
    • Background 323
    • Major Developments 323
    • Contact Details 324
  • Ferndale Pharma Group 325
    • Snapshot 325
    • Background 325
    • Products 325
    • Major Developments 326
    • Contact Details 326
  • Fougera 327
    • Snapshot 327
    • Background 327
    • Products 327
    • Major developments 328
    • Contact Details 329
  • G&W Laboratories 330
    • Snapshot 330
    • Background 330
    • Products 330
    • Contact Details 331
  • GeneraMedix Pharmaceuticals 332
    • Snapshot 332
    • Background 332
    • Products 332
    • Major Developments 333
    • Contact Details 333
  • Greenstone 334
    • Snapshot 334
    • Background 334
    • Products 334
    • Major Developments 334
    • Contact Details 335
  • Handa Pharmaceuticals 336
    • Snapshot 336
    • Background 336
    • Products 336
    • Major Developments 336
    • Contact Details 337
  • Hanford Pharmaceuticals 338
    • Snapshot 338
    • Background 338
    • Products 338
    • Major Developments 338
    • Contact Details 339
  • Harris Pharmaceutical 340
    • Snapshot 340
    • Background 340
    • Products 340
    • Contact Details 340
  • Hi-Tech Pharmacal 341
    • Snapshot 341
    • Background 341
    • Products 341
    • Financials 342
    • Major Developments 343
    • Contact Details 344
  • IGI Laboratories 345
    • Snapshot 345
    • Background 345
    • Products 345
    • Financials 345
    • Major Developments 346
    • Contact Details 346
  • Indicus Pharma 347
    • Snapshot 347
    • Background 347
    • Products 347
    • Contact Details 348
  • InvaGen Pharmaceuticals 349
    • Snapshot 349
    • Background 349
    • Products 349
    • Contact Details 350
  • Kadmon Pharmaceuticals 351
    • Snapshot 351
    • Background 351
    • Products 351
    • Major Developments 351
    • Contact Details 352
  • Kremers Urban Pharmaceuticals 353
  • Snapshot 353
    • Background 353
    • Products 353
    • Major Developments 354
    • Contact Details 354
  • KVK-Tech 355
    • Snapshot 355
    • Background 355
    • Products 355
    • Major Developments 355
    • Contact Details 356
  • Lehigh Valley Technologies 357
    • Snapshot 357
    • Background 357
    • Products 357
    • Major Developments 357
    • Contact Details 358
  • Luitpold Pharmaceuticals 359
    • Snapshot 359
    • Background 359
    • Products 359
    • Major Developments 361
    • Contact Details 362
  • Lyne Laboratories 363
    • Snapshot 363
    • Background 363
    • Products 363
    • Contact Details 363
  • Mallinckrodt 364
    • Snapshot 364
    • Background 364
    • Products 364
    • Major Developments 365
    • Contact Details 366
  • Mikart 367
    • Snapshot 367
    • Background 367
    • Products 367
    • Contact Details 368
  • Nexgen Pharma 369
    • Snapshot 369
    • Background 369
    • Products 369
    • Contact Details 369
  • Nexus Pharmaceuticals 370
    • Snapshot 370
    • Background 370
    • Products 370
    • Major Developments 370
    • Contact Details 371
  • Nostrum Pharmaceuticals 372
    • Snapshot 372
    • Background 372
    • Products 372
    • Major Developments 372
    • Contact Details 373
  • Novel Laboratories 374
    • Snapshot 374
    • Background 374
    • Products 374
    • Major Developments 375
    • Contact Details 375
  • Orit Laboratories 376
    • Snapshot 376
    • Background 376
    • Products 376
    • Contact Details 376
  • Osmotica Pharmaceutical 377
    • Snapshot 377
    • Background 377
    • Products 377
    • Major Developments 378
    • Contact Details 378
  • Patheon 379
    • Snapshot 379
    • Background 379
    • Products 379
    • Financials 380
    • Major Developments 381
    • Contact Details 382
  • Pharmaceutical Associates 383
    • Snapshot 383
    • Background 383
    • Products 383
    • Contact Details 383
  • Prasco Laboratories 384
    • Snapshot 384
    • Background 384
    • Products 384
    • Major Developments 384
    • Contact Details 386
  • Precision Dose 387
    • Snapshot 387
    • Background 387
    • Products 387
    • Major Developments 387
    • Contact Details 388
  • Qualitest Pharmaceuticals 389
    • Snapshot 389
    • Background 389
    • Products 389
    • Financials 391
    • Major Developments 392
    • Contact Details 392
  • Roxane Laboratories 393
    • Snapshot 393
    • Background 393
    • Products 393
    • Major Developments 395
    • Contact Details 396
  • Sigmapharm Laboratories 397
    • Snapshot 397
    • Background 397
    • Products 397
    • Contact Details 397
  • Silarx Pharmaceuticals 398
    • Snapshot 398
    • Background 398
    • Products 398
    • Contact Details 398
  • SOHM 399
    • Snapshot 399
    • Background 399
    • Products 399
    • Financials 399
    • Major Developments 400
    • Contact Details 401
  • Spear Pharmaceuticals 402
    • Snapshot 402
    • Background 402
    • Products 402
    • Major Developments 402
    • Contact Details 402
  • Stason Pharmaceuticals 403
    • Snapshot 403
    • Background 403
    • Products 403
    • Major Developments 403
    • Contact Details 404
  • Tolmar 405
    • Snapshot 405
    • Background 405
    • Products 405
    • Major Developments 405
    • Contact Details 406
  • Tris Pharma 407
    • Snapshot 407
    • Background 407
    • Products 407
    • Major Developments 408
    • Contact Details 408
  • Upsher-Smith Laboratories 409
    • Snapshot 409
    • Background 409
    • Products 409
    • Major Developments 410
    • Contact Details 410
  • VersaPharm 411
    • Snapshot 411
    • Background 411
    • Products 411
    • Contact Details 412
  • VistaPharm 413
    • Snapshot 413
    • Background 413
    • Products 413
    • Contact Details 413
  • X-GEN Pharmaceutical 414
    • Snapshot 414
    • Background 414
    • Products 414
    • Major Developments 414
    • Contact Details 415

Vietnam 416

  • Nanogen Biopharmaceutical 416
    • Snapshot 416
    • Background 416
    • Products 416
    • Contact Details 416

學名藥:全球市場的聯盟的機會是由出版商Espicom Business Intelligence在2014年01月20日所出版的。這份市場調查報告書包含438 Pages 價格從美金1250起跳。

Back to Top
;